Mitsubishi UFJ Asset Management Co., Ltd.
Position in CADL — Candel Therapeutics, Inc.
CIK 1466546
TOKYO, M0
Position in CADL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$301,130
New position
Shares Held
29,236
first reported quarter
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 138 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Asset Management Co., Ltd. holds $743,827,492 across 74 Biotechnology names. CADL ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
647,193 | $321,480,178 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
257,450 | $160,530,373 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
168,664 | $50,772,923 | |
| 4 | INCY |
Incyte Corp
|
412,258 | $46,733,566 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
186,924 | $35,007,126 | |
| 6 | MRNA |
Moderna, Inc.
|
450,036 | $31,516,021 | |
| 7 | INSM |
INSMED Inc
|
289,594 | $30,876,512 | |
| 8 | RPRX |
Royalty Pharma plc
|
472,798 | $26,509,783 |
All Filings in CADL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,130 | 29,236 | Shares | Defined | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||